β-Ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression.
- DOI
- 10.1016/j.bioactmat.2024.10.029
- Published
- 2025 Feb
- Container
- Bioactive materials
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bioactmat.2024.10.029,
title = {β-Ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression.},
author = {Yan T and Liao Q and Chen Z and Xu Y and Zhu W and Hu P and Zhang S and Wu Y and Shu L and Liu J and Luo M and Shu H and Sheng Y and Wang L and Xu C and Lei C and Wang H and Ye Q and Yang L and Zhu X},
year = {2025},
journal = {Bioactive materials},
doi = {10.1016/j.bioactmat.2024.10.029},
url = {https://doi.org/10.1016/j.bioactmat.2024.10.029}
}RIS
TY - JOUR TI - β-Ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression. AU - Yan T AU - Liao Q AU - Chen Z AU - Xu Y AU - Zhu W AU - Hu P AU - Zhang S AU - Wu Y AU - Shu L AU - Liu J AU - Luo M AU - Shu H AU - Sheng Y AU - Wang L AU - Xu C AU - Lei C AU - Wang H AU - Ye Q AU - Yang L AU - Zhu X PY - 2025 JO - Bioactive materials DO - 10.1016/j.bioactmat.2024.10.029 UR - https://doi.org/10.1016/j.bioactmat.2024.10.029 ER -
APA
T, Y., Q, L., Z, C., Y, X., W, Z., P, H., S, Z., Y, W., L, S., J, L., M, L., H, S., Y, S., L, W., C, X., C, L., H, W., Q, Y., L, Y., & X, Z. (2025). β-Ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression.. Bioactive materials. https://doi.org/10.1016/j.bioactmat.2024.10.029
Source records
- pubmed · retrieved 2026-11-10T13:28:10.871Z